Listed

Regeneron Pharmaceuticals, Inc.

REGNNasdaqCIK 872589HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$4.29bn, Q2 FY2026
Operating income$1.29bn, Q2 FY2026
Net income$1.30bn, Q2 FY2026
Regeneron Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m3,363Revenue, Q3 FY2023, three months to 2023-09-30$3.36bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure3,434Revenue, Q4 FY2023, three months to 2023-12-31$3.43bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure3,145Revenue, Q1 FY2024, three months to 2024-03-31$3.15bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure3,547Revenue, Q2 FY2024, three months to 2024-06-30$3.55bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure3,721Revenue, Q3 FY2024, three months to 2024-09-30$3.72bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure3,789Revenue, Q4 FY2024, three months to 2024-12-31$3.79bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure3,029Revenue, Q1 FY2025, three months to 2025-03-31$3.03bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure3,676Revenue, Q2 FY2025, three months to 2025-06-30$3.68bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure3,754Revenue, Q3 FY2025, three months to 2025-09-30$3.75bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure3,884Revenue, Q4 FY2025, three months to 2025-12-31$3.88bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure3,605Revenue, Q1 FY2026, three months to 2026-03-31$3.61bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure4,291Revenue, Q2 FY2026, three months to 2026-06-30$4.29bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m1,075Research and development, Q3 FY2023, three months to 2023-09-30$1.08bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure1,177Research and development, Q4 FY2023, three months to 2023-12-31$1.18bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1,248Research and development, Q1 FY2024, three months to 2024-03-31$1.25bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure1,200Research and development, Q2 FY2024, three months to 2024-06-30$1.20bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure1,272Research and development, Q3 FY2024, three months to 2024-09-30$1.27bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure1,412Research and development, Q4 FY2024, three months to 2024-12-31$1.41bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1,327Research and development, Q1 FY2025, three months to 2025-03-31$1.33bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure1,422Research and development, Q2 FY2025, three months to 2025-06-30$1.42bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure1,475Research and development, Q3 FY2025, three months to 2025-09-30$1.48bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure1,626Research and development, Q4 FY2025, three months to 2025-12-31$1.63bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1,544Research and development, Q1 FY2026, three months to 2026-03-31$1.54bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure1,632Research and development, Q2 FY2026, three months to 2026-06-30$1.63bn. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Selling, general and administrative$m641Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$640.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure738Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$737.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure689Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$689.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure759Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$758.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure714Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$714.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure792Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$792.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure633Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$633.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure634Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$634.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure658Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$657.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure775Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$775.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure648Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$647.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure662Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$662.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Operating income$m1,111Operating income, Q3 FY2023, three months to 2023-09-30$1.11bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure973Operating income, Q4 FY2023, three months to 2023-12-31$972.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure751Operating income, Q1 FY2024, three months to 2024-03-31$751.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure1,070Operating income, Q2 FY2024, three months to 2024-06-30$1.07bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure1,180Operating income, Q3 FY2024, three months to 2024-09-30$1.18bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure990Operating income, Q4 FY2024, three months to 2024-12-31$990.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure592Operating income, Q1 FY2025, three months to 2025-03-31$591.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure1,080Operating income, Q2 FY2025, three months to 2025-06-30$1.08bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure1,027Operating income, Q3 FY2025, three months to 2025-09-30$1.03bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure880Operating income, Q4 FY2025, three months to 2025-12-31$879.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure643Operating income, Q1 FY2026, three months to 2026-03-31$642.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure1,294Operating income, Q2 FY2026, three months to 2026-06-30$1.29bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Interest expense$m17.8Interest expense, Q3 FY2023, three months to 2023-09-30$17.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-02, accession 0001804220-23-000031.Report this figure18.3Interest expense, Q4 FY2023, three months to 2023-12-31$18.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-05, accession 0001804220-24-000009. Derived: 12-month figure less the 9-month figure.Report this figure16.1Interest expense, Q1 FY2024, three months to 2024-03-31$16.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-02, accession 0001804220-24-000017.Report this figure14.8Interest expense, Q2 FY2024, three months to 2024-06-30$14.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure13.8Interest expense, Q3 FY2024, three months to 2024-09-30$13.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure10.5Interest expense, Q4 FY2024, three months to 2024-12-31$10.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure8.7Interest expense, Q1 FY2025, three months to 2025-03-31$8.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure3.6Interest expense, Q2 FY2025, three months to 2025-06-30$3.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure19.3Interest expense, Q3 FY2025, three months to 2025-09-30$19.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure12.2Interest expense, Q4 FY2025, three months to 2025-12-31$12.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure12.9Interest expense, Q1 FY2026, three months to 2026-03-31$12.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure11.0Interest expense, Q2 FY2026, three months to 2026-06-30$11.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Income tax$m103Income tax, Q3 FY2023, three months to 2023-09-30$103.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure(12.0)Income tax, Q4 FY2023, three months to 2023-12-31−$12.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(21.3)Income tax, Q1 FY2024, three months to 2024-03-31−$21.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure196Income tax, Q2 FY2024, three months to 2024-06-30$195.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure152Income tax, Q3 FY2024, three months to 2024-09-30$152.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure40.4Income tax, Q4 FY2024, three months to 2024-12-31$40.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure96.3Income tax, Q1 FY2025, three months to 2025-03-31$96.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure127Income tax, Q2 FY2025, three months to 2025-06-30$127.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure303Income tax, Q3 FY2025, three months to 2025-09-30$303.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure199Income tax, Q4 FY2025, three months to 2025-12-31$199.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure104Income tax, Q1 FY2026, three months to 2026-03-31$104.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure231Income tax, Q2 FY2026, three months to 2026-06-30$230.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Net income$m1,008Net income, Q3 FY2023, three months to 2023-09-30$1.01bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure1,160Net income, Q4 FY2023, three months to 2023-12-31$1.16bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure722Net income, Q1 FY2024, three months to 2024-03-31$722.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure1,432Net income, Q2 FY2024, three months to 2024-06-30$1.43bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure1,341Net income, Q3 FY2024, three months to 2024-09-30$1.34bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure918Net income, Q4 FY2024, three months to 2024-12-31$917.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure809Net income, Q1 FY2025, three months to 2025-03-31$808.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure1,392Net income, Q2 FY2025, three months to 2025-06-30$1.39bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure1,460Net income, Q3 FY2025, three months to 2025-09-30$1.46bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure845Net income, Q4 FY2025, three months to 2025-12-31$844.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure727Net income, Q1 FY2026, three months to 2026-03-31$727.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure1,297Net income, Q2 FY2026, three months to 2026-06-30$1.30bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Diluted EPS$ per share8.89Diluted EPS, Q3 FY2023, three months to 2023-09-30$8.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figurenot reported6.27Diluted EPS, Q1 FY2024, three months to 2024-03-31$6.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure12.41Diluted EPS, Q2 FY2024, three months to 2024-06-30$12.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure11.54Diluted EPS, Q3 FY2024, three months to 2024-09-30$11.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figurenot reported7.27Diluted EPS, Q1 FY2025, three months to 2025-03-31$7.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure12.81Diluted EPS, Q2 FY2025, three months to 2025-06-30$12.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure13.62Diluted EPS, Q3 FY2025, three months to 2025-09-30$13.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figurenot reported6.75Diluted EPS, Q1 FY2026, three months to 2026-03-31$6.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure12.23Diluted EPS, Q2 FY2026, three months to 2026-06-30$12.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Basic EPS$ per share9.48Basic EPS, Q3 FY2023, three months to 2023-09-30$9.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figurenot reported6.70Basic EPS, Q1 FY2024, three months to 2024-03-31$6.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure13.25Basic EPS, Q2 FY2024, three months to 2024-06-30$13.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure12.40Basic EPS, Q3 FY2024, three months to 2024-09-30$12.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figurenot reported7.58Basic EPS, Q1 FY2025, three months to 2025-03-31$7.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure13.24Basic EPS, Q2 FY2025, three months to 2025-06-30$13.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure14.09Basic EPS, Q3 FY2025, three months to 2025-09-30$14.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figurenot reported6.99Basic EPS, Q1 FY2026, three months to 2026-03-31$6.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure12.62Basic EPS, Q2 FY2026, three months to 2026-06-30$12.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure

Balance sheet

Cash and equivalents$2.46bn, Q2 FY2026
Long-term debt$1.99bn, Q2 FY2026
Shareholders' equity$31.71bn, Q2 FY2026
Regeneron Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$bn2.2Cash and equivalents, Q3 FY2023, at 2023-09-30$2.15bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure2.7Cash and equivalents, FY2023, at 2023-12-31$2.73bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-04, accession 0000872589-26-000008.Report this figure2.6Cash and equivalents, Q1 FY2024, at 2024-03-31$2.60bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure1.9Cash and equivalents, Q2 FY2024, at 2024-06-30$1.92bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure2.0Cash and equivalents, Q3 FY2024, at 2024-09-30$2.01bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure2.5Cash and equivalents, FY2024, at 2024-12-31$2.49bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-04, accession 0000872589-26-000008.Report this figure3.1Cash and equivalents, Q1 FY2025, at 2025-03-31$3.09bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure2.0Cash and equivalents, Q2 FY2025, at 2025-06-30$2.00bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure2.5Cash and equivalents, Q3 FY2025, at 2025-09-30$2.51bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure3.1Cash and equivalents, FY2025, at 2025-12-31$3.12bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure3.0Cash and equivalents, Q1 FY2026, at 2026-03-31$2.96bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure2.5Cash and equivalents, Q2 FY2026, at 2026-06-30$2.46bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Current assets$bn18.6Current assets, Q3 FY2023, at 2023-09-30$18.63bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0001804220-23-000031.Report this figure19.5Current assets, FY2023, at 2023-12-31$19.48bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-05, accession 0001804220-25-000011.Report this figure18.9Current assets, Q1 FY2024, at 2024-03-31$18.87bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001804220-24-000017.Report this figure19.1Current assets, Q2 FY2024, at 2024-06-30$19.08bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0001804220-24-000028.Report this figure19.3Current assets, Q3 FY2024, at 2024-09-30$19.33bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure18.7Current assets, FY2024, at 2024-12-31$18.66bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-04, accession 0000872589-26-000008.Report this figure17.6Current assets, Q1 FY2025, at 2025-03-31$17.57bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure16.9Current assets, Q2 FY2025, at 2025-06-30$16.86bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure18.0Current assets, Q3 FY2025, at 2025-09-30$17.98bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure18.0Current assets, FY2025, at 2025-12-31$18.02bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure18.2Current assets, Q1 FY2026, at 2026-03-31$18.21bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure18.4Current assets, Q2 FY2026, at 2026-06-30$18.45bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Total assets$bn32.2Total assets, Q3 FY2023, at 2023-09-30$32.16bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0001804220-23-000031.Report this figure33.1Total assets, FY2023, at 2023-12-31$33.08bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-05, accession 0001804220-25-000011.Report this figure34.4Total assets, Q1 FY2024, at 2024-03-31$34.37bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001804220-24-000017.Report this figure36.1Total assets, Q2 FY2024, at 2024-06-30$36.09bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0001804220-24-000028.Report this figure37.4Total assets, Q3 FY2024, at 2024-09-30$37.44bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure37.8Total assets, FY2024, at 2024-12-31$37.76bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-04, accession 0000872589-26-000008.Report this figure37.5Total assets, Q1 FY2025, at 2025-03-31$37.55bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure38.2Total assets, Q2 FY2025, at 2025-06-30$38.22bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure40.2Total assets, Q3 FY2025, at 2025-09-30$40.17bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure40.6Total assets, FY2025, at 2025-12-31$40.56bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure40.9Total assets, Q1 FY2026, at 2026-03-31$40.87bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure41.7Total assets, Q2 FY2026, at 2026-06-30$41.73bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Current liabilities$bn3.6Current liabilities, Q3 FY2023, at 2023-09-30$3.60bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0001804220-23-000031.Report this figure3.4Current liabilities, FY2023, at 2023-12-31$3.42bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-05, accession 0001804220-25-000011.Report this figure3.6Current liabilities, Q1 FY2024, at 2024-03-31$3.58bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001804220-24-000017.Report this figure3.5Current liabilities, Q2 FY2024, at 2024-06-30$3.51bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0001804220-24-000028.Report this figure3.7Current liabilities, Q3 FY2024, at 2024-09-30$3.66bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure3.9Current liabilities, FY2024, at 2024-12-31$3.94bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-04, accession 0000872589-26-000008.Report this figure3.6Current liabilities, Q1 FY2025, at 2025-03-31$3.57bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure3.7Current liabilities, Q2 FY2025, at 2025-06-30$3.67bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure4.4Current liabilities, Q3 FY2025, at 2025-09-30$4.43bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure4.4Current liabilities, FY2025, at 2025-12-31$4.37bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure5.1Current liabilities, Q1 FY2026, at 2026-03-31$5.11bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure5.5Current liabilities, Q2 FY2026, at 2026-06-30$5.53bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Total liabilities$bn7.3Total liabilities, Q3 FY2023, at 2023-09-30$7.26bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0001804220-23-000031.Report this figure7.1Total liabilities, FY2023, at 2023-12-31$7.11bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-05, accession 0001804220-25-000011.Report this figure7.4Total liabilities, Q1 FY2024, at 2024-03-31$7.38bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0001804220-24-000017.Report this figure7.9Total liabilities, Q2 FY2024, at 2024-06-30$7.88bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0001804220-24-000028.Report this figure8.1Total liabilities, Q3 FY2024, at 2024-09-30$8.12bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure8.4Total liabilities, FY2024, at 2024-12-31$8.41bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-04, accession 0000872589-26-000008.Report this figure8.2Total liabilities, Q1 FY2025, at 2025-03-31$8.16bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure8.3Total liabilities, Q2 FY2025, at 2025-06-30$8.28bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure9.2Total liabilities, Q3 FY2025, at 2025-09-30$9.21bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure9.3Total liabilities, FY2025, at 2025-12-31$9.30bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure9.4Total liabilities, Q1 FY2026, at 2026-03-31$9.45bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure10.0Total liabilities, Q2 FY2026, at 2026-06-30$10.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Long-term debt$bn2.0Long-term debt, Q3 FY2023, at 2023-09-30$1.98bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-02, accession 0001804220-23-000031.Report this figure2.0Long-term debt, FY2023, at 2023-12-31$1.98bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-05, accession 0001804220-25-000011.Report this figure2.0Long-term debt, Q1 FY2024, at 2024-03-31$1.98bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-02, accession 0001804220-24-000017.Report this figure2.0Long-term debt, Q2 FY2024, at 2024-06-30$1.98bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-01, accession 0001804220-24-000028.Report this figure2.0Long-term debt, Q3 FY2024, at 2024-09-30$1.98bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure2.0Long-term debt, FY2024, at 2024-12-31$1.98bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-04, accession 0000872589-26-000008.Report this figure2.0Long-term debt, Q1 FY2025, at 2025-03-31$1.98bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure2.0Long-term debt, Q2 FY2025, at 2025-06-30$1.99bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure2.0Long-term debt, Q3 FY2025, at 2025-09-30$1.99bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure2.0Long-term debt, FY2025, at 2025-12-31$1.99bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure2.0Long-term debt, Q1 FY2026, at 2026-03-31$1.99bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure2.0Long-term debt, Q2 FY2026, at 2026-06-30$1.99bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure
Short-term borrowings$bnnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$bn24.9Shareholders' equity, Q3 FY2023, at 2023-09-30$24.90bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure26.0Shareholders' equity, FY2023, at 2023-12-31$25.97bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-04, accession 0000872589-26-000008.Report this figure27.0Shareholders' equity, Q1 FY2024, at 2024-03-31$26.99bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure28.2Shareholders' equity, Q2 FY2024, at 2024-06-30$28.21bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure29.3Shareholders' equity, Q3 FY2024, at 2024-09-30$29.33bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure29.4Shareholders' equity, FY2024, at 2024-12-31$29.35bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure29.4Shareholders' equity, Q1 FY2025, at 2025-03-31$29.39bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure29.9Shareholders' equity, Q2 FY2025, at 2025-06-30$29.94bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure31.0Shareholders' equity, Q3 FY2025, at 2025-09-30$30.96bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure31.3Shareholders' equity, FY2025, at 2025-12-31$31.26bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure31.4Shareholders' equity, Q1 FY2026, at 2026-03-31$31.42bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure31.7Shareholders' equity, Q2 FY2026, at 2026-06-30$31.71bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure

Cash flow

Operating cash flow$813.0m, Q2 FY2026
Capital expenditure$240.2m, Q2 FY2026
Share repurchases$1.17bn, Q2 FY2026
Regeneron Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m1,114Operating cash flow, Q3 FY2023, three months to 2023-09-30$1.11bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-31, accession 0001804220-24-000040. Derived: 9-month figure less the 6-month figure.Report this figure1,090Operating cash flow, Q4 FY2023, three months to 2023-12-31$1.09bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1,513Operating cash flow, Q1 FY2024, three months to 2024-03-31$1.51bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure354Operating cash flow, Q2 FY2024, three months to 2024-06-30$354.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-01, accession 0000872589-25-000019. Derived: 6-month figure less the 3-month figure.Report this figure1,291Operating cash flow, Q3 FY2024, three months to 2024-09-30$1.29bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0000872589-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure1,263Operating cash flow, Q4 FY2024, three months to 2024-12-31$1.26bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1,045Operating cash flow, Q1 FY2025, three months to 2025-03-31$1.05bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure1,144Operating cash flow, Q2 FY2025, three months to 2025-06-30$1.14bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0000872589-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure1,619Operating cash flow, Q3 FY2025, three months to 2025-09-30$1.62bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0000872589-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure1,171Operating cash flow, Q4 FY2025, three months to 2025-12-31$1.17bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1,079Operating cash flow, Q1 FY2026, three months to 2026-03-31$1.08bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure813Operating cash flow, Q2 FY2026, three months to 2026-06-30$813.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0000872589-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m176Capital expenditure, Q3 FY2023, three months to 2023-09-30$176.0m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2024-10-31, accession 0001804220-24-000040. Derived: 9-month figure less the 6-month figure.Report this figure251Capital expenditure, Q4 FY2023, three months to 2023-12-31$251.4m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure134Capital expenditure, Q1 FY2024, three months to 2024-03-31$133.9m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure181Capital expenditure, Q2 FY2024, three months to 2024-06-30$180.5m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-08-01, accession 0000872589-25-000019. Derived: 6-month figure less the 3-month figure.Report this figure242Capital expenditure, Q3 FY2024, three months to 2024-09-30$241.9m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-10-28, accession 0000872589-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure200Capital expenditure, Q4 FY2024, three months to 2024-12-31$199.6m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure229Capital expenditure, Q1 FY2025, three months to 2025-03-31$229.3m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure219Capital expenditure, Q2 FY2025, three months to 2025-06-30$219.0m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-07-30, accession 0000872589-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure201Capital expenditure, Q3 FY2025, three months to 2025-09-30$201.4m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-10-28, accession 0000872589-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure249Capital expenditure, Q4 FY2025, three months to 2025-12-31$248.7m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure231Capital expenditure, Q1 FY2026, three months to 2026-03-31$230.6m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure240Capital expenditure, Q2 FY2026, three months to 2026-06-30$240.2m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-07-30, accession 0000872589-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$mnot reportednot reported0.0Dividends paid, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure0.0Dividends paid, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-08-01, accession 0000872589-25-000019. Derived: 6-month figure less the 3-month figure.Report this figure0.0Dividends paid, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-10-28, accession 0000872589-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure0.0Dividends paid, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure93.8Dividends paid, Q1 FY2025, three months to 2025-03-31$93.8m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure92.6Dividends paid, Q2 FY2025, three months to 2025-06-30$92.6m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-07-30, accession 0000872589-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure91.2Dividends paid, Q3 FY2025, three months to 2025-09-30$91.2m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-10-28, accession 0000872589-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure92.7Dividends paid, Q4 FY2025, three months to 2025-12-31$92.7m. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure97.8Dividends paid, Q1 FY2026, three months to 2026-03-31$97.8m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure96.8Dividends paid, Q2 FY2026, three months to 2026-06-30$96.8m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-07-30, accession 0000872589-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m547Share repurchases, Q3 FY2023, three months to 2023-09-30$546.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-10-31, accession 0001804220-24-000040. Derived: 9-month figure less the 6-month figure.Report this figure289Share repurchases, Q4 FY2023, three months to 2023-12-31$289.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure291Share repurchases, Q1 FY2024, three months to 2024-03-31$291.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure604Share repurchases, Q2 FY2024, three months to 2024-06-30$603.9m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-01, accession 0000872589-25-000019. Derived: 6-month figure less the 3-month figure.Report this figure735Share repurchases, Q3 FY2024, three months to 2024-09-30$735.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-28, accession 0000872589-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure973Share repurchases, Q4 FY2024, three months to 2024-12-31$973.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1,041Share repurchases, Q1 FY2025, three months to 2025-03-31$1.04bn. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure1,062Share repurchases, Q2 FY2025, three months to 2025-06-30$1.06bn. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-30, accession 0000872589-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure664Share repurchases, Q3 FY2025, three months to 2025-09-30$664.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-28, accession 0000872589-25-000028. Derived: 9-month figure less the 6-month figure.Report this figure672Share repurchases, Q4 FY2025, three months to 2025-12-31$671.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-04, accession 0000872589-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure794Share repurchases, Q1 FY2026, three months to 2026-03-31$794.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure1,169Share repurchases, Q2 FY2026, three months to 2026-06-30$1.17bn. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-30, accession 0000872589-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)106.00m, Q2 FY2026
Regeneron Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares113Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30112,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0001804220-23-000031.Report this figure114Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31114,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001804220-24-000017.Report this figure114Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30113,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0001804220-24-000028.Report this figure113Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30113,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0001804220-24-000040.Report this figure115Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31115,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-29, accession 0001804220-25-000022.Report this figure115Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30115,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-01, accession 0000872589-25-000019.Report this figure116Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30116,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure111Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31111,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure109Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30108,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure107Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30107,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0000872589-25-000028.Report this figure108Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31107,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-29, accession 0000872589-26-000016.Report this figure106Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30106,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0000872589-26-000025.Report this figure

Shares outstanding: 93.96mShares outstanding, period not labelled, at 2012-07-1393,955,110 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2012-07-25, accession 0001206774-12-003062.Report this figure at Jul 13, 2012, from the cover of the 10-Q filed Jul 25, 2012.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. Listed shows no prices and gives no investment advice.